Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041200076Recruiting
Open-label, single-arm trial of remimazolam in None. Primary endpoint: Pharmacokinetics of Remimazolam. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041200076.